An Overview of Multifunctional Metal Chelators as Potential Treatments for Neurodegenerative Diseases
Authors:
- Frank W. LewisFLFrank W. Lewis
- David TétardDTDavid Tétard
- 1 January 2017
- book chapter
- Published by Elsevier
- p. 399-414
Abstract
No abstract availableThis publication has 72 references indexed in Scilit:
- A Bioinorganic View of Alzheimer’s Disease: When Misplaced Metal Ions (Re)direct the Electrons to the Wrong TargetChemistry – A European Journal, 2012
- Werner coordination chemistry and neurodegenerationChemical Society Reviews, 2012
- Mammalian iron metabolism and its control by iron regulatory proteinsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Therapeutic Redistribution of Metal Ions To Treat Alzheimer’s DiseaseAccounts of Chemical Research, 2012
- Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative diseasesPharmacology & Therapeutics, 2012
- Alzheimer's disease & metals: therapeutic opportunitiesBritish Journal of Pharmacology, 2011
- Biological metals and Alzheimer's disease: Implications for therapeutics and diagnosticsProgress in Neurobiology, 2010
- Therapeutics for Alzheimer's Disease Based on the Metal HypothesisNeurotherapeutics, 2008
- Metal based neurodegenerative diseases—From molecular mechanisms to therapeutic strategiesCoordination Chemistry Reviews, 2008
- Iron misregulation in the brain: a primary cause of neurodegenerative disordersThe Lancet Neurology, 2003